نظام الأسد بوصفه نظامًًا أقلويًًا: تماسك الجماعة الطائفية وآليات البقاء
سياسات عربية · 30.11.2026 · 9
DOI: 10.31430/yakj7511 ↗Kurz gefasst
Fachartikel in der Zeitschrift سياسات عربية, online erschienen am 30.11.2026. Verfasst von سلام السعدي.
Abstract (Originalsprache)
This paper examines the sources of the Assad regime’s durability in Syria, and revisits prevailing explanations of its resilience. Existing scholarship has largely emphasized the regime’s "social contract", attributing its endurance to alliances with diverse classbased and regional constituencies within Syrian society. While these dynamics are central during periods of relative stability, they become insufficient for explaining regime survival during moments of profound crisis, when legitimacy erodes, resources dwindle, and the regime confronts direct existential threats. This paper argues that in such critical junctures, broad social coalitions give way to more decisive factors-most notably elite cohesion and the regime’s willingness and capacity to deploy intensive and systematic repression. Building on this perspective, the paper advances an alternative explanation for the Syrian regime’s endurance that does not rest on sectarianism or clientelism per se, but rather on a distinctive minority-rule structure that generated fear of Sunni majority rule. This fear rendered loyalty to the regime a rational defensive behavior rather than an expression of inherent sectarian loyalty, thereby contributing to the regime’s resilience and its ability to withstand the 2011 uprising.
Zitieren
APA
السعدي, س. (2026). نظام الأسد بوصفه نظامًًا أقلويًًا: تماسك الجماعة الطائفية وآليات البقاء. سياسات عربية, 9. https://doi.org/10.31430/yakj7511
Vancouver
السعدي س. نظام الأسد بوصفه نظامًًا أقلويًًا: تماسك الجماعة الطائفية وآليات البقاء. سياسات عربية. 2026:9. doi:10.31430/yakj7511
BibTeX
@article{2026,
author = {السعدي, سلام},
title = {نظام الأسد بوصفه نظامًًا أقلويًًا: تماسك الجماعة الطائفية وآليات البقاء},
journal = {سياسات عربية},
year = {2026},
pages = {9},
doi = {10.31430/yakj7511}
}
EUVIMED